Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000667970 | SCV000792502 | likely pathogenic | Deficiency of butyryl-CoA dehydrogenase | 2017-06-26 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000667970 | SCV001560639 | uncertain significance | Deficiency of butyryl-CoA dehydrogenase | 2023-05-08 | criteria provided, single submitter | clinical testing | This variant disrupts a region of the ACADS protein in which other variant(s) (p.Arg23Trp) have been observed in individuals with ACADS-related conditions (Invitae). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. ClinVar contains an entry for this variant (Variation ID: 552667). This variant has not been reported in the literature in individuals affected with ACADS-related conditions. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This sequence change affects the initiator methionine of the ACADS mRNA. The next in-frame methionine is located at codon 40. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Genome- |
RCV000667970 | SCV002033233 | likely pathogenic | Deficiency of butyryl-CoA dehydrogenase | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Laboratory of Medical Genetics, |
RCV000667970 | SCV005051722 | pathogenic | Deficiency of butyryl-CoA dehydrogenase | 2024-02-01 | criteria provided, single submitter | curation |